Interactive effects of morphine on HIV infection: Role in HIV-associated neurocognitive disorder

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Reddy, Pichili Vijaya Bhaskar ^a   Pilakka Kanthikeel, Sudheesh ^a   Saxena, Shailendra K ^b   Saiyed, Zainulabedin ^a   Nair, Madhavan P N ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865086333     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/953678     Document Type: Review

References (107)

1. Antinori A., Arendt G., Becker J. T., Brew B. J., Byrd D. A., Cherner M., Clifford D. B., Cinque P., Epstein L. G., Goodkin K., Gisslen M., Grant I., Heaton R. K., Joseph J., Marder K., Marra C. M., McArthur J. C., Nunn M., Price R. W., Pulliam L., Robertson K. R., Sacktor N., Valcour V., Wojna V. E., Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007 69 18 1789 1799 2-s2.0-35848953181 10.1212/01.WNL.0000287431.88658.8b (Pubitemid 350059308)
2. Goodkin K., Wilkie F. L., Concha M., Hinkin C. H., Symes S., Baldewicz T. T., Asthana D., Fujimura R. K., Lee D., van Zuilen M. H., Khamis I., Shapshak P., Eisdorfer C., Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. Journal of Clinical Epidemiology 2001 54 12, supplement 1 S35 S43 2-s2.0-0035660282 10.1016/S0895-4356(01)00445-0 (Pubitemid 34019142)
3. McArthur J. C., Hoover D. R., Bacellar H., Dementia in AIDS patients: incidence and risk factors. multicenter AIDS Cohort Study. Neurology 1993 43 2245 2252 (Pubitemid 23346956)
4. Mintz M., Clinical comparison of adult and pediatric NeuroAIDS. Advances in Neuroimmunology 1994 4 3 207 221 2-s2.0-0028139228 (Pubitemid 24325866)
5. Robertson K. R., Hall C. D., Human immunodeficiency virus-related cognitive impairment and the acquired immunodeficiency syndrome dementia complex. Seminars in Neurology 1992 12 1 18 27 2-s2.0-0026516989
6. Zheng J., Gendelman H. E., The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Current Opinion in Neurology 1997 10 4 319 325 2-s2.0-0030860925 (Pubitemid 27355011)
7. Beyrer C., Razak M. H., Lisam K., Chen J., Lui W., Yu X. F., Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 2000 14 1 75 83 2-s2.0-0033979507 10.1097/00002030-200001070-00009 (Pubitemid 30072080)
8. Bokhari S. M., Hegde R., Callen S., Yao H., Adany I., Li Q., Li Z., Pinson D., Yeh H. W., Cheney P. D., Buch S., Morphine potentiates neuropathogenesis of SIV infection in Rhesus Macaques. Journal of Neuroimmune Pharmacology 2011 1 14 2-s2.0-79952732650 10.1007/s11481-011-9272-9
9. Bokhari S. M., Yao H., Bethel-Brown C., Fuwang P., Williams R., Dhillon N. K., Hegde R., Kumar A., Buch S. J., Morphine enhances Tat-induced activation in murine microGlia. Journal of NeuroVirology 2009 15 3 219 228 2-s2.0-70450237701 10.1080/13550280902913628
10. Donahoe R. M., Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model. Journal of Neuroimmunology 2004 147 1-2 28 32 2-s2.0-1642452588 10.1016/j.jneuroim.2003.10.011 (Pubitemid 38114942)
11. Francis H., Substance abuse and HIV infection. Topics in HIV Medicine 2003 11 1 20 24 2-s2.0-0038317695
12. Kapadia F., Vlahov D., Donahoe R. M., Friedland G., The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clinical Infectious Diseases 2005 41 7 1027 1034 2-s2.0-25444495620 10.1086/433175 (Pubitemid 41368228)
13. Vaswani M., Desai N. G., HIV infection and high-risk behaviors in opioid dependent patients: the Indian context. Addictive Behaviors 2004 29 8 1699 1705 2-s2.0-4644299679 10.1016/j.addbeh.2004.01.008 (Pubitemid 39296540)
14. Bell J. E., Anthony I. C., Simmonds P., Impact of HIV on regional & cellular organization of the brain. Current HIV Research 2006 4 3 249 257 2-s2.0-33745851534 10.2174/157016206777709401 (Pubitemid 44027715)
15. Bell J. E., Brettle R. P., Chiswick A., Simmonds P., HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 1998 121 11 2043 2052 2-s2.0-0031764403 10.1093/brain/121.11.2043 (Pubitemid 28497903)
16. Nath A., Maragos W. F., Avison M. J., Schmitt F. A., Berger J. R., Acceleration of HIV dementia with methamphetamine and cocaine. Journal of NeuroVirology 2001 7 1 66 71 2-s2.0-0034798531 10.1080/135502801300069737 (Pubitemid 32904361)
17. Ellis R., Langford D., Masliah E., HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nature Reviews Neuroscience 2007 8 1 33 44 2-s2.0-33845775666 10.1038/nrn2040 (Pubitemid 46011997)
18. McArthur J. C., Brew B. J., HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS 2010 24 9 1367 1370 2-s2.0-77952902769 10.1097/QAD.0b013e3283391d56
19. Nath A., Hauser K. F., Wojna V., Molecular basis for interactions of HIV and drugs of abuse. Journal of Acquired Immune Deficiency Syndromes 2002 31 supplement 2 S62 S69 (Pubitemid 35190560)
20. Eisenstein T. K., Hilburger M. E., Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. Journal of Neuroimmunology 1998 83 1-2 36 44 2-s2.0-0032520733 10.1016/S0165-5728(97)00219-1 (Pubitemid 28280949)
21. Messmer D., Hatsukari I., Hitosugi N., Schmidt-Wolf I. G. H., Singhal P. C., Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Molecular Medicine 2006 12 11-12 284 290 2-s2.0-33947615694 10.2119/2006-00043.Messmer (Pubitemid 46489821)
22. Rivera-Amill V., Silverstein P. S., Noel R. J., Kumar S., Kumar A., Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution. Journal of Neuroimmune Pharmacology 2010 5 1 122 132 2-s2.0-77249166003 10.1007/s11481-009-9184-0
23. Saurer T. B., Carrigan K. A., Ijames S. G., Lysle D. T., Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. Journal of Neuroimmunology 2006 173 1-2 3 11 2-s2.0-33644953806 10.1016/j.jneuroim.2005.11.009
24. Wang J., Barke R. A., Ma J., Charboneau R., Roy S., Opiate abuse, innate immunity, and bacterial infectious diseases. Archivum Immunologiae et Therapia Experimentalis (Warsz) 2008 56 299 309
25. Hauser K. F., El-Hage N., Buch S., Berger J. R., Tyor W. R., Nath A., Bruce-Keller A. J., Knapp P. E., Molecular targets of opiate drug abuse in neuroAIDS. Neurotoxicity Research 2005 8 1-2 63 80 2-s2.0-33644841358 10.1007/BF03033820
26. Nath A., Anderson C., Jones M., Maragos W., Booze R., Mactutus C., Bell J., Hauser K., Mattson M., Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. Journal of Psychopharmacology 2000 14 3 222 227 2-s2.0-0033746611
27. Dronda F., Zamora J., Moreno S., Moreno A., Casado J. L., Muriel A., Pérez-Elías M. J., Antela A., Moreno L., Quereda C., CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use. AIDS 2004 18 16 2210 2212 2-s2.0-7744242891 10.1097/00002030-200411050-00018 (Pubitemid 39463691)
28. Kumar R., Torres C., Yamamura Y., Rodriguez I., Martinez M., Staprans S., Donahoe R. M., Kraiselburd E., Stephens E. B., Kumar A., Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. Journal of Virology 2004 78 20 11425 11428 2-s2.0-4644230492 10.1128/JVI.78.20.11425-11428.2004 (Pubitemid 39299687)
29. Banda N. K., Bernier J., Kurahara D. K., Kurrle R., Haigwood N., Sekaly-R. P., Finkel T. H., Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. Journal of Experimental Medicine 1992 176 4 1099 1106 2-s2.0-0026784923
30. Gougeon M. L., Montagnier L., Apoptosis in AIDS. Science 1993 260 5112 1269 1270 2-s2.0-0027297036 (Pubitemid 23231968)
31. Li C. J., Friedman D. J., Wang C., Metelev V., Pardee A. B., Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995 268 5209 429 431 2-s2.0-0029062573
32. + cells expressing gp160 of human immunodeficiency virus type 1. Journal of Virology 1994 68 1 390 399 2-s2.0-0027979260
33. Peterson P. K., Gekker G., Hu S., Anderson W. R., Kravitz F., Portoghese P. S., Balfour H. H., Chao C. C., Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. Journal of Neuroimmunology 1994 50 2 167 175 2-s2.0-0028344853 10.1016/0165-5728(94)90043-4 (Pubitemid 24071782)
34. Peterson P. K., Gekker G., Schut R., Hu S., Balfour H. H., Chao C. C., Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Advances in Experimental Medicine and Biology 1993 335 181 188 2-s2.0-0027496534 (Pubitemid 23294312)
35. Nair M. P. N., Schwartz S. A., Polasani R., Hou J., Sweet A., Chadha K. C., Immunoregulatory effects of morphine on human lymphocytes. Clinical and Diagnostic Laboratory Immunology 1997 4 2 127 132 2-s2.0-0030895404 (Pubitemid 27130222)
36. Moorman J., Zhang Y., Liu B., HIV-1 gp120 primes lymphocytes for opioid-induced, beta-arrestin 2-dependent apoptosis. Biochimica et Biophysica Acta 2009 1793 1366 1371
37. Rojavin M., Szabo I., Bussiere J. L., Rogers T. J., Adler M. W., Eisenstein T. K., Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sciences 1993 53 12 997 1006 2-s2.0-0027239461
38. Zhang N., Oppenheim J. J., Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems. Journal of Leukocyte Biology 2005 78 6 1210 1214 2-s2.0-28844445067 10.1189/jlb.0405224 (Pubitemid 41779226)
39. Beltran J. A., Pallur A., Chang S. L., HIV-1 gp120 up-regulation of the mu opioid receptor in TPA-differentiated HL-60 cells. International Immunopharmacology 2006 6 9 1459 1467 2-s2.0-33745840202 10.1016/j.intimp.2006. 04.018 (Pubitemid 44038689)
40. Peterson P. K., Gekker G., Lokensgard J. R., Bidlack J. M., Chang A. C., Fang X., Portoghese P. S., κ -opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes. Biochemical Pharmacology 2001 61 9 1145 1151 2-s2.0-0035342409 10.1016/S0006-2952(01)00574-3 (Pubitemid 32285481)
41. Lokensgard J. R., Gekker G., Peterson P. K., κ -Opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4+ lymphocytes. Biochemical Pharmacology 2002 63 6 1037 1041 2-s2.0-0037087640 10.1016/S0006-2952(02)00875-4 (Pubitemid 34267018)
42. Hauser K. F., Hahn Y. K., Adjan V. V., Zou S., Buch S. K., Nath A., Bruce-Keller A. J., Knapp P. E., HIV-1 tat and morphine have interactive effects on oligodendrocyte survival and morphology. Glia 2009 57 2 194 206 2-s2.0-60549089453 10.1002/Glia.20746
43. Hu S., Sheng W. S., Lokensgard J. R., Peterson P. K., Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. Journal of Infectious Diseases 2005 191 6 886 889 2-s2.0-14844293853 10.1086/427830 (Pubitemid 40349803)
44. Malik S., Khalique H., Buch S., Seth P., A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases. PLoS ONE 2011 6 3 2-s2.0-79953043204 10.1371/journal.pone.0018116 e18116
45. Kaul M., Garden G. A., Lipton S. A., Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001 410 6831 988 994 2-s2.0-0035912198 10.1038/35073667 (Pubitemid 32335850)
46. Gurwell J. A., Nath A., Sun Q., Zhang J., Martin K. M., Chen Y., Hauser K. F., Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 2001 102 3 555 563 2-s2.0-0035808842 10.1016/S0306-4522(00)00461-9 (Pubitemid 32171876)
47. Mahajan S. D., Schwartz S. A., Shanahan T. C., Chawda R. P., Nair M. P., Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroGlial cells via the opioid mu receptor. The Journal of Immunology 2002 169 3589 3599
48. El-Hage N., Wu G., Wang J., Ambati J., Knapp P. E., Reed J. L., Bruce-Keller A. J., Hauser K. F., HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microGlia through the expression of MCP-1 and alternative chemokines. Glia 2006 53 2 132 146 2-s2.0-33644796067 10.1002/Glia.20262
49. Mahajan S. D., Schwartz S. A., Aalinkeel R., Chawda R. P., Sykes D. E., Nair M. P. N., Morphine modulates chemokine gene regulation in normal human astrocytes. Clinical Immunology 2005 115 3 323 332 2-s2.0-19144364834 10.1016/j.clim.2005.02.004 (Pubitemid 40716049)
50. El-Hage N., Bruce-Keller A. J., Yakovleva T., Bazov I., Bakalkin G., Knapp P. E., Hauser K. F., Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca2+]i, NF- κ B trafficking and transcription. PLoS ONE 2008 3 12 2-s2.0-58149339916 10.1371/journal.pone.0004093 e4093
51. Dong Y., Benveniste E. N., Immune function of astrocytes. Glia 2001 36 2 180 190 2-s2.0-0035153212 10.1002/Glia.1107 (Pubitemid 33055906)
52. Allan S. M., Rothwell N. J., Inflammation in central nervous system injury. Philosophical Transactions of the Royal Society B 2003 358 1438 1669 1677 2-s2.0-0142185061 10.1098/rstb.2003.1358 (Pubitemid 37298635)
53. Rahman A., Harvey K., Siddiqui R. A., Interleukin-8: an autocrine inflammatory mediator. Current Pharmaceutical Design 1999 5 4 241 253 2-s2.0-0033046956 (Pubitemid 29185834)
54. Baggiolini M., Clark-Lewis I., Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Letters 1992 307 1 97 101 2-s2.0-0026643195 10.1016/0014-5793(92)80909-Z
55. Shah A., Kumar A., HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF- κ B pathway and can be silenced by gp120-specific siRNA. Journal of Neuroinflammation 2010 7, article 96 2-s2.0-78650591264 10.1186/1742-2094-7-96
56. Sherwood E. R., Prough D. S., Interleukin-8, neuroinflammation, and secondary brain injury. Critical Care Medicine 2000 28 4 1221 1223 2-s2.0-0034019390 (Pubitemid 30262108)
57. Meddows-Taylor S., Martin D. J., Tiemessen C. T., Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis. Journal of Infectious Diseases 1998 177 4 921 930 2-s2.0-0031968878 (Pubitemid 28155144)
58. Stantchev T. S., Broder C. C., Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors. Cytokine and Growth Factor Reviews 2001 12 2-3 219 243 2-s2.0-0034955071 10.1016/S1359- 6101(00)00033-2 (Pubitemid 32588147)
59. 2+ and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 tat. Glia 2005 50 2 91 106 2-s2.0-18244409652 10.1002/Glia.20148 (Pubitemid 40695264)
60. Bruce-Keller A. J., Barger S. W., Moss N. I., Pham J. T., Keller J. N., Nath A., Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microGlial cell line: attenuation by 17 β -estradiol. Journal of Neurochemistry 2001 78 6 1315 1324 2-s2.0-0034810579 10.1046/j.1471-4159.2001. 00511.x (Pubitemid 32899763)
61. Turchan-Cholewo J., Dimayuga F. O., Gupta S., Keller J. N., Knapp P. E., Hauser K. F., Bruce-Keller A. J., Morphine and HIV-Tat increase microGlial-free radical production and oxidative stress: possible role in cytokine regulation. Journal of Neurochemistry 2009 108 1 202 215 2-s2.0-57249086430 10.1111/j.1471-4159.2008.05756.x
62. Lusso P., HIV and chemokines: implications for therapy and vaccine. Vaccine 2002 20 15 1964 1967 2-s2.0-0037029863 10.1016/S0264-410X(02)00079-8 (Pubitemid 34450795)
63. Verani A., Lusso P., Chemokines as natural HIV antagonists. Current Molecular Medicine 2002 2 8 691 702 2-s2.0-0036893491 10.2174/1566524023361862 (Pubitemid 35385969)
64. Asensio V. C., Campbell L. L., Chemokines and viral diseases of the central nervous system. Advances in Virus Research 2001 56 127 173 2-s2.0-0035222868 (Pubitemid 33804560)
65. Dorf M. E., Berman M. A., Tanabe S., Heesen M., Luo Y., Astrocytes express functional chemokine receptors. Journal of Neuroimmunology 2000 111 1-2 109 121 2-s2.0-0034332964 10.1016/S0165-5728(00)00371-4
66. Conant K., Garzino-Demo A., Nath A., Mcarthur J. C., Halliday W., Power C., Gallo R. C., Major E. O., Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proceedings of the National Academy of Sciences of the United States of America 1998 95 6 3117 3121 2-s2.0-0032539828 10.1073/pnas.95.6.3117 (Pubitemid 28135864)
67. Eugenin E. A., Osiecki K., Lopez L., Goldstein H., Calderon T. M., Berman J. W., CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. Journal of Neuroscience 2006 26 4 1098 1106 2-s2.0-32544437823 10.1523/JNEUROSCI.3863-05.2006 (Pubitemid 43237041)
68. Kelder W., McArthur J. C., Nance-Sproson T., McClernon D., Griffin D. E., β -Chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Annals of Neurology 1998 44 5 831 835 2-s2.0-0031737417 (Pubitemid 28516058)
69. McManus C. M., Weidenheim K., Woodman S. E., Nunez J., Hesselgesser J., Nath A., Berman J. W., Chemokine and chemokine-receptor expression in human Glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. American Journal of Pathology 2000 156 4 1441 1453 2-s2.0-0033843359 (Pubitemid 30660019)
70. Lehner T., The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection. Trends in Immunology 2002 23 7 347 351 2-s2.0-0036644347 10.1016/S1471-4906(02)02252-4 (Pubitemid 34717911)
71. Murakami T., Yamamoto N., Roles of chemokines and chemokine receptors in HIV-1 infection. International Journal of Hematology 2000 72 4 412 417 2-s2.0-0034568757
72. Mankowski J. L., Queen S. E., Clements J. E., Zink M. C., Cerebrospinal fluid markers that predict SIV CNS disease. Journal of Neuroimmunology 2004 157 1-2 66 70 2-s2.0-9644283129 10.1016/j.jneuroim.2004.08.031 (Pubitemid 39576639)
73. Sevigny J. J., Albert S. M., McDermott M. P., McArthur J. C., Sacktor N., Conant K., Schifitto G., Selnes O. A., Stern Y., McClernon D. R., Palumbo D., Kieburtz K., Riggs G., Cohen B., Epstein L. G., Marder K., Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 2004 63 11 2084 2090 2-s2.0-10444241256 (Pubitemid 39636256)
74. Rock R. B., Hu S., Sheng W. S., Peterson P. K., Morphine stimulates CCL2 production by human neurons. Journal of Neuroinflammation 2006 3, article 32 2-s2.0-33845769353 10.1186/1742-2094-3-32 (Pubitemid 46002455)
75. Wetzel M. A., Steele A. D., Eisenstein T. K., Adler M. W., Henderson E. E., Rogers T. J., μ -Opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN- γ -inducible protein-10 expression in human peripheral blood mononuclear cells. Journal of Immunology 2000 165 11 6519 6524 2-s2.0-0034548719
76. El-Hage N., Wu G., Ambati J., Bruce-Keller A. J., Knapp P. E., Hauser K. F., CCR2 mediates increases in Glial activation caused by exposure to HIV-1 Tat and opiates. Journal of Neuroimmunology 2006 178 1-2 9 16 2-s2.0-33748101228 10.1016/j.jneuroim.2006.05.027 (Pubitemid 44307341)
77. Vallejo R., de Leon-Casasola O., Benyamin R., Opioid therapy and immunosuppression: a review. American Journal of Therapeutics 2004 11 5 354 365 2-s2.0-16544378494
78. Gallo R. C., Garzino-Demo A., DeVico A. L., HIV infection and pathogenesis: what about chemokines? Journal of Clinical Immunology 1999 19 5 293 299 2-s2.0-0032857669 10.1023/A:1020539524373 (Pubitemid 29489394)
79. Garzino-Demo A., DeVico A. L., Cocchi F., Gallo R. C., Beta-chemokines and protection from HIV type 1 disease. AIDS Research and Human Retroviruses 1998 14 S177 S184 2-s2.0-0032091053
80. Garzino-Demo A., Devico A. L., Gallo R. C., Chemokine receptors and chemokines in HIV infection. Journal of Clinical Immunology 1998 18 4 243 255 2-s2.0-0031857365 10.1023/A:1027329721892 (Pubitemid 28374063)
81. Howard O. M., Oppenheim J. J., Wang J. M., Chemokines as molecular targets for therapeutic intervention. Journal of Clinical Immunology 1999 19 5 280 292 2-s2.0-0032884283 10.1023/A:1020587407535 (Pubitemid 29489393)
82. Kinter A., Arthos J., Cicala C., Fauci A. S., Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis. Immunological Reviews 2000 177 88 98 2-s2.0-0033659666
83. Lane T. E., Asensio V. C., Yu N., Paoletti A. D., Campbell I. L., Buchmeier M. J., Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. The Journal of Immunology 1998 160 970 978 (Pubitemid 28049342)
84. Mahajan S. D., Aalinkeel R., Reynolds J. L., Nair B. B., Fernandez S. F., Schwartz S. A., Nair M. P. N., Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Current HIV Research 2005 3 3 277 288 2-s2.0-22944479298 10.2174/ 1570162054368048 (Pubitemid 41052427)
85. Miller M. D., Krangel M. S., Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Critical Reviews in Immunology 1992 12 1-2 17 46 2-s2.0-0026776079
86. El-Hage N., Bruce-Keller A. J., Knapp P. E., Hauser K. F., CCL5/RANTES gene deletion attenuates opioid-induced increases in Glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice. Journal of Neuroimmune Pharmacology 2008 3 4 275 285 2-s2.0-55849095473 10.1007/s11481-008-9127-1
87. Kitai R., Zhao M. L., Zhang N., Hua L. L., Lee S. C., Role of MIP-1 β and RANTES in HIV-1 infection of microGlia: inhibition of infection and induction by IFN β Journal of Neuroimmunology 2000 110 1-2 230 239 2-s2.0-0034596585 10.1016/S0165-5728(00)00315-5
88. Sasseville V. G., Smith M. M., Mackay C. R., Pauley D. R., Mansfield K. G., Ringler D. J., Lackner A. A., Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. American Journal of Pathology 1996 149 5 1459 1467 2-s2.0-0029951709 (Pubitemid 26363952)
89. Li Y., Merrill J. D., Mooney K., Song L., Wang X., Guo C. J., Savani R. C., Metzger D. S., Douglas S. D., Ho W. Z., Morphine enhances HIV infection of neonatal macrophages. Pediatric Research 2003 54 2 282 288 2-s2.0-10744222658 10.1203/01.PDR.0000074973.83826.4C (Pubitemid 36918165)
90. Steele A. D., Henderson E. E., Rogers T. J., μ -Opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 2003 309 1 99 107 2-s2.0-0037466528 10.1016/S0042-6822(03)00015-1 (Pubitemid 36506593)
91. Gutkind J. S., The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. The Journal of Biological Chemistry 1998 273 4 1839 1842 2-s2.0-0031893949 10.1074/jbc.273.4.1839 (Pubitemid 28069221)
92. Chen C., Farooqui M., Gupta K., Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells. Current Neurovascular Research 2006 3 3 171 180 2-s2.0-33746893866 10.2174/ 156720206778018767 (Pubitemid 44198470)
93. Gupta K., Kshirsagar S., Chang L., Schwartz R., Law P. Y., Yee D., Hebbel R. P., Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Research 2002 62 15 4491 4498 2-s2.0-0036682055 (Pubitemid 34827313)
94. Jacqué J. M., Mann A., Enslen H., Sharova N., Brichacek B., Davis R. J., Stevenson M., Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. The EMBO Journal 1998 17 9 2607 2618 2-s2.0-0032079658 10.1093/emboj/17.9.2607 (Pubitemid 28221196)
95. Popik W., Hesselgesser J. E., Pitha P. M., Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. Journal of Virology 1998 72 8 6406 6413 2-s2.0-0031927822 (Pubitemid 28323952)
96. Yang X., Gabuzda D., Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. Journal of Virology 1999 73 4 3460 3466 2-s2.0-0032974805 (Pubitemid 29135742)
97. Frank D. A., Greenberg M. E., CREB: a mediator of long-term memory from mollusks to mammals. Cell 1994 79 1 5 8 2-s2.0-0028108923 10.1016/0092-8674(94) 90394-8 (Pubitemid 24309507)
98. Martin K. C., Kandel E. R., Cell adhesion molecules, CREB, and the formation of new synaptic connections. Neuron 1996 17 4 567 570 2-s2.0-0030272962 10.1016/S0896-6273(00)80188-9 (Pubitemid 26365335)
99. Silva A. J., Kogan J. H., Frankland P. W., Kida S., CREB and memory. Annual Review of Neuroscience 1998 21 127 148 2-s2.0-0031898726 10.1146/annurev.neuro.21.1.127 (Pubitemid 28150661)
100. Wen H., Lu Y., Yao H., Buch S., Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability. PLoS ONE 2011 6 6 2-s2.0-79959596087 10.1371/journal.pone.0021707 e21707
101. Wang J., Barke R. A., Charboneau R., Loh H. H., Roy S., Morphine negatively regulates interferon- γ promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. The Journal of Biological Chemistry 2003 278 39 37622 37631 2-s2.0-0141509934 10.1074/jbc.M301224200 (Pubitemid 37175285)
102. Deuel T. F., Polypeptide growth factors: roles in normal and abnormal cell growth. Annual Review of Cell Biology 1987 3 443 492 2-s2.0-0023505080
103. Hannink M., Donoghue D. J., Structure and function of platelet-derived growth factor (PDGF) and related proteins. Biochimica et Biophysica Acta 1989 989 1 1 10 2-s2.0-0024315697 (Pubitemid 19180347)
104. Heldin C. H., Structural and functional studies on platelet-derived growth factor. The EMBO Journal 1992 11 12 4251 4259 2-s2.0-0026445368
105. Potula R., Dhillion N., Sui Y., Zien C. A., Funa K., Pinson D., Mayo M. S., Singh D. K., Narayan O., Buch S., Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. American Journal of Pathology 2004 165 3 815 824 2-s2.0-4344672704 (Pubitemid 39129289)
106. Su E. J., Fredriksson L., Geyer M., Folestad E., Cale J., Andrae J., Gao Y., Pietras K., Mann K., Yepes M., Strickland D. K., Betsholtz C., Eriksson U., Lawrence D. A., Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nature Medicine 2008 14 7 731 737 2-s2.0-46749118298 10.1038/nm1787
107. Yao H., Duan M., Buch S., Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood 2011 117 8 2538 2547 2-s2.0-79952158505 10.1182/blood-2010-10-313593